Filtered By:
Condition: Heart Disease
Nutrition: Diets
This page shows you your search results in order of date. This is page number 18.
Order by Relevance | Date
Total 617 results found since Jan 2013.
Development of a Mobile Application Platform for Self-Management of Obesity Using Artificial Intelligence Techniques
Int J Telemed Appl. 2021 Aug 27;2021:6624057. doi: 10.1155/2021/6624057. eCollection 2021.ABSTRACTObesity is a major global health challenge and a risk factor for the leading causes of death, including heart disease, stroke, diabetes, and several types of cancer. Attempts to manage and regulate obesity have led to the implementation of various dietary regulatory initiatives to provide information on the calorie contents of meals. Although knowledge of the calorie content is useful for meal planning, it is not sufficient as other factors, including health status (diabetes, hypertension, etc.) and level of physical activity,...
Source: International Journal of Telemedicine and Applications - September 6, 2021 Category: Information Technology Authors: Sylvester M Sefa-Yeboah Kwabena Osei Annor Valencia J Koomson Firibu K Saalia Matilda Steiner-Asiedu Godfrey A Mills Source Type: research
Vegetable nitrate intake, blood pressure and incident cardiovascular disease: Danish Diet, Cancer, and Health Study
AbstractWhether the vascular effects of inorganic nitrate, observed in clinical trials, translate to a reduction in cardiovascular disease (CVD) with habitual dietary nitrate intake in prospective studies warrants investigation. We aimed to determine if vegetable nitrate, the major dietary nitrate source, is associated with lower blood pressure (BP) and lower risk of incident CVD. Among 53,150 participants of the Danish Diet, Cancer, and Health Study, without CVD at baseline, vegetable nitrate intake was assessed using a comprehensive vegetable nitrate database. Hazard ratios (HRs) were calculated using restricted cubic sp...
Source: European Journal of Epidemiology - August 1, 2021 Category: Epidemiology Source Type: research
Janssen Submits New Drug Application to U.S. FDA for XARELTO ® (rivaroxaban) to Help Prevent and Treat Blood Clots in Pediatric Patients
RARITAN, NJ, June 23, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for the use of XARELTO® (rivaroxaban) in pediatric patients. The NDA seeks two pediatric indications: treatment of venous thromboembolism (VTE, or blood clots) and reduction in the risk of recurrent VTE in patients aged birth to less than 18 years of age after at least five days of initial parenteral anticoagulant treatment; and thromboprophylaxis (prevention of blood clots) in patients aged 2 years and older with congenita...
Source: Johnson and Johnson - June 23, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news
Potassium
Adv Food Nutr Res. 2021;96:89-121. doi: 10.1016/bs.afnr.2021.02.013. Epub 2021 May 24.ABSTRACTPotassium is an essential nutrient that performs a vital role in cellular functions including maintaining fluid balance and osmolality of cells. Potassium balance is maintained by the kidney and the majority of ingested potassium is excreted in the urine. There is strong evidence of a negative association between dietary potassium and blood pressure, and some evidence (much of it indirect) of negative associations between dietary potassium and cardiovascular disease (particularly stroke and coronary heart disease) and kidney disea...
Source: Advances in Food and Nutrition Research - June 11, 2021 Category: Nutrition Authors: Rachael Mira McLean Nan Xin Wang Source Type: research
